Eli Lilly Loses Supreme Court Bid Over False Claims Act Whistleblower Suits

The Supreme Court declined to hear Eli Lilly’s challenge to the False Claims Act’s whistleblower system, leaving in place a judgment of more than $183 million tied to Medicaid rebate allegations. Reuters reported that Lilly argued the law’s qui tam provision gives private citizens unconstitutional power to sue on the government’s behalf.

The decision does not mean the Supreme Court ruled that the whistleblower system is constitutional. It means the justices declined to take Lilly’s case, leaving the lower-court result intact.

Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →

The case drew attention from legal and business circles because the issue reaches far beyond Lilly. The U.S. Chamber of Commerce supported review, arguing the Court should hold the qui tam provisions unconstitutional. Legal discussion on LinkedIn and Reddit focused on whether whistleblowers are needed fraud watchdogs or private enforcers with too much power.

For future cases, whistleblower lawsuits remain viable for now, but constitutional challenges are likely to continue.

Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →